- Condition: Pharmacogenetic Testing
Intervention:
Sponsors: Duke University; Duke University; National Institute of General Medical Sciences (NIGMS)
Not yet recruiting - verified May 2012 - Condition: Neuroblastoma
Interventions: Drug: MLN8237; Drug: Irinotecan; Drug: Temozolomide
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Active, not recruiting - verified May 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: PLX3397; Drug: Eribulin
Sponsors: University of California, San Francisco; Hope Rugo, MD; Susan G. Komen Breast Cancer Foundation; Plexxikon, Inc.; Eisai Inc.
Not yet recruiting - verified May 2012 - Condition: Eye Manifestations
Intervention:
Sponsors: Duke University; Duke University; Bioptigen, Inc.
Recruiting - verified April 2012 - Conditions: Heart Failure; Heart Diseases; Cardiovascular Diseases
Intervention: Behavioral: Usual heart failure care + interdisciplinary palliative care
Sponsors: Duke University; Duke University; National Institute of Nursing Research (NINR)
Not yet recruiting - verified April 2012 - Conditions: Neuroblastoma; Pheochromocytoma; Paraganglioma
Intervention: Radiation: I-131 MIBG
Sponsors: Jubilant DraxImage Inc.; Jubilant DraxImage Inc.
Available - verified April 2012 - Condition: Neuroblastoma
Interventions: Biological: ch14.18 -NCI; Biological: ch14.18-UTC; Biological: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF); Biological: Aldesleukin (IL-2); Drug: Isotretinoin
Sponsors: United Therapeutics; United Therapeutics
Not yet recruiting - verified May 2012 - Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis
Intervention: Other: Observational
Sponsors: Johns Hopkins University; Johns Hopkins University; University of Alabama at Birmingham; Boston University; Mayo Clinic; Duke University; The Cleveland Clinic; University Medical Centre Groningen
Enrolling by invitation - verified April 2012 - Conditions: Type 2 Diabetes; Overweight; Obesity
Interventions: Behavioral: Weight Watchers modified program; Other: Standard Care group
Sponsors: Medical University of South Carolina; Medical University of South Carolina; Weight Watchers International
Recruiting - verified March 2012 - Condition: Neuroblastoma
Intervention:
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Recruiting - verified April 2012 - Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: External Fixation; Procedure: Percutaneous Pinning; Procedure: Closed Reduction and casting
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Ventilator-associated Pneumonia
Intervention: Procedure: Daily SAT & SBT
Sponsors: Harvard Pilgrim Health Care; Harvard Pilgrim Health Care; Centers for Disease Control and Prevention; Washington University School of Medicine; Rush University Medical Center; University of Pennsylvania; Duke University; North Shore Medical Center
Recruiting - verified May 2012 - Condition: Sickle Cell Disease
Intervention: Drug: NiCord
Sponsors: Gamida Cell ltd; Gamida Cell ltd
Recruiting - verified May 2012 - Conditions: Multidrug Resistant Organisms; Healthcare Associated Infections
Interventions: Other: Quaternary ammonium; Other: Bleach; Other: Quaternary ammonium and UV-C light; Other: Bleach and UV-C light
Sponsors: Duke University; Duke University
Active, not recruiting - verified April 2012 - Condition: Ventricular Tachycardia
Interventions: Drug: amiodarone; Drug: sotalol; Device: Biosense Webster's NAVI-STAR Thermo-Cool
Sponsors: Duke University; Duke University; Duke Clinical Research Institute
Not yet recruiting - verified April 2012 - Condition: Endometritis
Intervention: Drug: Ertapenem
Sponsors: Duke University; Duke University
Recruiting - verified April 2012 - Conditions: Carcinoid Tumor of the Small Bowel; Neuroendocrine Tumour
Interventions: Drug: Octreotide; Drug: Octreotide; Drug: 177Lu-DOTA0-Tyr3-Octreotate
Sponsors: Advanced Accelerator Applications; Advanced Accelerator Applications; Pierrel Research Europe GmbH
Not yet recruiting - verified April 2012 - Conditions: Early Detection of Cancer; Colon Cancer; Decision Making; Patient-Centered Care
Interventions: Behavioral: Making A Decision About CRC Screening; Behavioral: Drivers 65 Plus
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Duke University; Agency for Healthcare Research and Quality (AHRQ)
Enrolling by invitation - verified April 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: darunavir/cobicistat/emtricitabine/GS-7340; Drug: darunavir + cobicistat + emtricitabine/tenofovir df
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Conditions: Cigarette Smoking; Nicotine Dependence
Interventions: Drug: varenicline (Chantix); Drug: bupropion (Zyban) & nicotine patches; Drug: nicotine patches
Sponsors: Duke University; Duke University; Philip Morris USA, Inc.
Recruiting - verified May 2012 - Conditions: Unipolar Depression; Bipolar Depression
Interventions: Device: Sham tDCS device; Device: Soterix tDCS device
Sponsors: The University of New South Wales; The University of New South Wales; Duke University; Emory University; Sheppard Pratt Health System; University of Medicine and Dentistry New Jersey; University of Texas
Not yet recruiting - verified March 2012 - Condition: High Altitude Pulmonary Hypertension
Intervention: Drug: Theophylline and Bambuterol
Sponsors: Norwegian Armed Forces Medical Service; Norwegian Armed Forces Medical Service; Duke University; Oslo University Hospital
Recruiting - verified March 2012 - Conditions: Hepatic Impairment; Healthy
Intervention: Drug: Bardoxolone Methyl
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Chronic Kidney Disease Stage 5
Interventions: Other: Intradialytic aerobic exercise; Other: Progressive Muscle relaxation
Sponsors: Queen Margaret University; Queen Margaret University; British Kidney Patients Association
Not yet recruiting - verified May 2012 - Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Condition: Impaired Fasting Glucose
Interventions: Dietary Supplement: psyllium; Dietary Supplement: Microcrystalline Cellulose
Sponsors: Procter and Gamble; Procter and Gamble; Duke University
Recruiting - verified March 2012 - Conditions: Cord Blood Transplant; Hematologic Malignancy; Inherited Metabolic Disease
Intervention: Drug: TXA127
Sponsors: US Biotest, Inc.; US Biotest, Inc.; Tarix Pharmaceuticals
Recruiting - verified March 2012 - Condition: Morbid Obesity
Interventions: Device: Standard Laparoscopic Adjustable Gastric Band Surgery; Device: Plicated Laparoscopic Adjustable Gastric Band Surgery
Sponsors: Duke University; Duke University; Allergan
Not yet recruiting - verified April 2012 - Conditions: Neoplastic Syndrome; Neuroblastoma
Interventions: Genetic: gene expression analysis; Genetic: protein expression analysis; Other: enzyme-linked immunosorbent assay; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified March 2012 - Conditions: Brain Injuries; Craniocerebral Trauma
Intervention:
Sponsors: BrainScope Company, Inc.; BrainScope Company, Inc.
Not yet recruiting - verified May 2012 - Condition: Fragile X Syndrome
Intervention: Drug: arbaclofen
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Enrolling by invitation - verified March 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training; Behavioral: Online disease education
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting - verified February 2012 - Condition: Cirrhosis of the Liver
Intervention:
Sponsors: Northwestern University; Northwestern University; Loyola University
Recruiting - verified April 2012 - Condition: Post-Operative Pain
Interventions: Drug: Sufentanil NanoTab PCA System/15 mcg; Drug: Placebo Sufentanil NanoTab PCA System
Sponsors: AcelRx Pharmaceuticals, Inc.; AcelRx Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Infant, Newborn; Infant, Small for Gestational Age; Infant, Extremely Low Birth Weight
Interventions: Biological: Donor Breast Milk; Dietary Supplement: Preterm Formula
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Not yet recruiting - verified February 2012 - Condition: Chronic Hepatitis C
Interventions: Drug: GS-7977 in combination with ribavirin; Drug: GS 7977 placebo in combination with RBV placebo
Sponsors: Gilead Sciences; Gilead Sciences
Active, not recruiting - verified May 2012 - Condition: Cornea Tissue Preservation Time
Intervention: Biological: Cornea tissue transplant
Sponsors: Case Western Reserve University; Case Western Reserve University; National Eye Institute (NEI); Jaeb Center for Health Research
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Procedure: Massage Therapy
Sponsors: Duke University; Duke University; National Center for Complementary and Alternative Medicine (NCCAM)
Not yet recruiting - verified May 2012 - Condition: Frail Elders
Intervention: Behavioral: SingaPACE
Sponsors: National University, Singapore; National University, Singapore; Singapore General Hospital; Duke-NUS Graduate Medical School
Recruiting - verified March 2012 - Condition: Healthy
Interventions: Drug: Placebo; Drug: Meclizine; Drug: Meclizine
Sponsors: Duke University; Duke University; Wallace Foundation
Recruiting - verified February 2012 - Conditions: Asthma; Atopy
Interventions: Drug: fluticasone; Drug: Placebo
Sponsors: Milton S. Hershey Medical Center; dave mauger; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2012 - Condition: Bacterial Pneumonia
Interventions: Drug: IV meropenem; parenteral aminoglycoside; Drug: I.V. Meropenem
Sponsors: University of Florida; University of Florida
Not yet recruiting - verified March 2012 - Condition: High Altitude Pulmonary Hypertension
Interventions: Drug: Aminophylline; Drug: Ambrisentan; Drug: Aminophylline plus ambrisentan
Sponsors: Duke University; Duke University
Recruiting - verified March 2012 - Condition: Severe Aortic Stenosis
Intervention: Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Sponsors: Medtronic Cardiovascular; Medtronic Cardiovascular
Recruiting - verified April 2012 - Condition: HER2+ Cancer
Intervention: Biological: AVX901
Sponsors: Duke University; Duke University; Department of Defense
Not yet recruiting - verified February 2012 - Condition: Healthy Young Adults
Intervention: Device: Wii Fit
Sponsors: University of Rochester; University of Rochester
Completed - verified March 2012 - Conditions: Type 1 Diabetes; Eating Disorder
Intervention:
Sponsors: Duke University; Duke University; National Institute of Diabetes & Digestive & Kidney Diseases
Recruiting - verified January 2012 - Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: Lomitapide
Sponsors: Aegerion Pharmaceuticals, Inc.; Aegerion Pharmaceuticals, Inc.; University of Pennsylvania; Doris Duke Charitable Foundation
Completed - verified March 2012 - Condition: Prostate Cancer
Interventions: Drug: tasquinimod; Drug: tasquinimod 0.25 mg; 0.5 mg; Drug: tasquinimod 0.25 mg; 0.5 mg; 1.0 mg
Sponsors: Duke University; Duke University
Recruiting - verified January 2012 - Condition: Trisomy 21
Intervention:
Sponsors: Aria Diagnostics, Inc.; Aria Diagnostics, Inc.; Perinatal Quality Foundation: Nuchal Translucency Quality Review
Not yet recruiting - verified January 2012 - Condition: Postoperative Nausea and Vomiting
Interventions: Drug: APD421; Drug: Placebo
Sponsors: Acacia Pharma Ltd; Acacia Pharma Ltd
Recruiting - verified January 2012 - Condition: Hepatitis C
Intervention: Drug: BMS-914143
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Chronic Myocardial Ischemia; Refractory Angina Pectoris; (Advanced) Coronary Heart Disease
Interventions: Biological: Auto-CD34+ cells; Biological: Placebo: Diluent used to suspend Auto-CD34+ cells; Other: Standard of care
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified April 2012 - Conditions: Anemia; Unexplained Anemia
Interventions: Drug: Salsalate; Drug: Salsalate placebo
Sponsors: Duke University; Duke University; National Institute on Aging (NIA)
Not yet recruiting - verified January 2012 - Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
Sponsors: Kyowa Hakko Kirin Pharma, Inc.; Kyowa Hakko Kirin Pharma, Inc.; Kyowa Hakko Kirin Company, Limited
Recruiting - verified April 2012 - Condition: Acute Respiratory Distress Syndrome
Interventions: Drug: Aspirin; Drug: Lactose powder
Sponsors: Mayo Clinic; Ognjen Gajic; Beth Israel Deaconess Medical Center; Montefiore Medical Center; Vanderbilt University
Not yet recruiting - verified January 2012 - Condition: Refractory Urge Urinary Incontinence
Interventions: Device: InterStim® device; Drug: Botox® injection
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Duke University; University of Alabama at Birmingham; University of California, San Diego; The Cleveland Clinic; Brown University; University of New Mexico; University of Pennsylvania; University of Pittsburgh; Oregon Health and Science University; RTI International
Recruiting - verified February 2012 - Condition: Iatrogenic Injury
Intervention:
Sponsors: Florida State University; Florida State University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified February 2012 - Condition: Cognitive Impairment, no Dementia (CIND)
Interventions: Behavioral: Aerobic Exercise; Behavioral: DASH diet; Other: Health education control
Sponsors: Duke University; Duke University
Recruiting - verified April 2012 - Condition: Mantle-Cell Lymphoma
Intervention: Drug: Rituximab, Bortezomib,Y90 ibritumomab tiuxetan
Sponsors: Duke University; Duke University; Spectrum Pharmaceuticals, Inc
Recruiting - verified March 2012 - Conditions: Lambert-Eaton Myasthenic Syndrome; Eaton-Lambert Myasthenic Syndrome
Interventions: Drug: 3,4-DAP; Drug: 3,4-DAP Taper to Placebo
Sponsors: Jacobus Pharmaceutical; Jacobus Pharmaceutical
Enrolling by invitation - verified March 2012 - Conditions: Glioblastoma; Small Cell Glioblastoma; Giant Cell Glioblastoma; Gliosarcoma; Glioblastoma With Oligodendroglial Component; Recurrent Glioblastoma; Relapsed Glioblastoma
Interventions: Drug: Bevacizumab; Drug: Rindopepimut (CDX-110) with GM-CSF; Drug: KLH
Sponsors: Celldex Therapeutics; Celldex Therapeutics
Recruiting - verified May 2012 - Condition: Hepatitis C
Interventions: Drug: PSI-7977 in combination with ribavirin; Drug: Pegylated interferon in combination with ribavirin
Sponsors: Gilead Sciences; Gilead Sciences
Active, not recruiting - verified April 2012 - Conditions: Sarcoma, Soft Tissue; Osteosarcoma; Neoplasms, Connective and Soft Tissue
Intervention: Drug: Eltrombopag
Sponsors: Duke University; Duke University; GlaxoSmithKline
Enrolling by invitation - verified April 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/GS-7340; Drug: elvitegravir/cobicistat/emtricitabine/ tenofovir df
Sponsors: Gilead Sciences; Gilead Sciences
Active, not recruiting - verified April 2012 - Condition: Hepatitis C
Interventions: Drug: BMS-790052 (Daclatasvir); Drug: Telaprevir; Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Recurrent Supratentorial Glioblastoma Multiforme; GBM; Glioblastoma Multiforme
Intervention: Biological: Live attenuated, oral (Sabin) serotype 1 poliovirus vaccine (PVSRIPO)
Sponsors: Duke University; Duke University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Obesity; Hypertension
Intervention: Behavioral: Text Messaging and Behavior Counseling
Sponsors: Duke University; Duke University; The George Institute, China
Active, not recruiting - verified December 2011 - Condition: Solid Tumors
Intervention: Drug: Pazopanib and TH-302
Sponsors: Duke University; Duke University; National Comprehensive Cancer Network; GlaxoSmithKline; Threshold Pharmaceuticals
Recruiting - verified January 2012 - Condition: Hypertension
Intervention: Drug: Lisinopril
Sponsors: Duke University; Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified March 2012 - Conditions: Metastatic Colorectal Cancer; Colorectal Cancer
Interventions: Drug: MORAb-004; Drug: Placebo
Sponsors: Morphotek; Morphotek
Recruiting - verified May 2012 - Conditions: Ischemia; Vasopressor
Intervention: Drug: Injection of botulinum toxin A
Sponsors: Duke University; Duke University
Recruiting - verified May 2012 - Condition: Tinnitus
Interventions: Other: Sound Based and Educational Therapies; Other: Integrated Medicine Therapies and Sound Based Education Therapies; Other: Integrated Medicine Therapies and SBE
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified November 2011 - Condition: Prostate Cancer
Interventions: Drug: kanglaite gelcap; Drug: Kanglaite gelcap
Sponsors: KangLaiTe USA; KangLaiTe USA
Recruiting - verified November 2011 - Conditions: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma
Interventions: Drug: Alisertib; Drug: Pralatrexate; Drug: Romidepsin; Drug: Gemcitabine
Sponsors: Millennium Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Drug: veliparib; Genetic: gene expression analysis; Genetic: protein analysis; Other: laboratory biomarker analysis; Other: pharmacological study; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: National Cancer Institute (NCI); Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: CK-2017357; Drug: Placebo
Sponsors: Cytokinetics; Cytokinetics
Completed - verified March 2012 - Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Bendamustine + Rituximab + Pixantrone
Sponsors: Duke University; Duke University; Cell Therapeutics
Recruiting - verified March 2012 - Condition: Childhood Cancer
Interventions: Behavioral: FitFab 4 Survivors; Other: Wait List
Sponsors: Duke University; Duke University; National Cancer Institute (NCI)
Active, not recruiting - verified November 2011 - Conditions: Glioblastoma; Small Cell Glioblastoma; Giant Cell Glioblastoma; Gliosarcoma; Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF; Drug: Temozolomide; Drug: KLH
Sponsors: Celldex Therapeutics; Celldex Therapeutics
Recruiting - verified May 2012 - Condition: Complication of Transplanted Lung
Interventions: Drug: Aztreonam Lysine for Inhalation (AZLI); Procedure: Status Post Lung Transplant
Sponsors: Duke University; Duke University; Gilead Sciences
Not yet recruiting - verified April 2012 - Condition: Primary Biliary Cirrhosis
Interventions: Drug: Obeticholic Acid (OCA); Drug: Placebo
Sponsors: Intercept Pharmaceuticals; Intercept Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Arterial Hypertension
Intervention: Drug: UT-15C SR
Sponsors: United Therapeutics; United Therapeutics
Recruiting - verified February 2012 - Conditions: Obstetric Labor Complications; Post-partum Hemorrhage; Sepsis; Neonatal Infection
Interventions: Other: Improvements in quality of care; Other: Improvements in maternal and neonatal health outcomes
Sponsors: Duke University; Duke University; Stanford University; International Initiative for Impact Evaluation (3ie); UK Department for International Development (DFID); Sambodhi Research and Communication Pvt., Ltd.
Not yet recruiting - verified April 2012 - Condition: Pancreatic Cancer
Interventions: Drug: GS-6624; Drug: GS-6624; Drug: Placebo; Drug: Gemcitabine; Drug: Gemcitabine; Drug: Gemcitabine; Drug: Gemcitabine; Drug: GS-6624
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Generalized Anxiety Disorder (GAD); Anxiety, Separation; Phobia, Social
Interventions: Drug: SPD503 (extended-release Guanfacine hydrochloride); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified April 2012 - Condition: HIV-1 Infection
Interventions: Drug: Pravastatin sodium; Drug: Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate; Drug: Pravastatin sodium
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Cardiovascular Diseases; Coronary Disease; Coronary Artery Disease; Heart Diseases; Myocardial Ischemia
Interventions: Procedure: cardiac catheterization; Procedure: coronary artery bypass graft surgery; Procedure: percutaneous coronary intervention; Behavioral: Lifestyle; Drug: Medication
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); New York University; Vanderbilt University; Albany Stratton VA Medical Center; East Carolina University; Duke University; Harvard University; University of Missouri, Kansas City; Emory University; Cedars-Sinai Medical Center; Massachusetts General Hospital; University of Calgary; Columbia University; University of British Columbia
Not yet recruiting - verified April 2012 - Condition: Open Fracture
Intervention:
Sponsors: Major Extremity Trauma Research Consortium; Major Extremity Trauma Research Consortium; Department of Defense
Recruiting - verified December 2011 - Condition: Heart Failure
Interventions: Behavioral: Usual care; Behavioral: Rehabilitation intervention
Sponsors: Wake Forest University; Wake Forest University
Recruiting - verified January 2012 - Condition: Brain Injury
Intervention:
Sponsors: Duke University; Duke University
Recruiting - verified October 2011 - Condition: Nephrolithotomy
Intervention: Procedure: Standard Percutaneous nephrolithotomy
Sponsors: Duke University; Duke University
Completed - verified March 2012 - Conditions: Prematurity; Respiratory Insufficiency; Pulmonary Hypertension; Respiratory Distress Syndrome, Newborn
Interventions: Drug: Aerosolized Normal Saline; Drug: Inhaled PGE1
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Recruiting - verified February 2012 - Conditions: Aorta Aneurysm; Dissection of Aorta
Intervention: Drug: Clevidipine
Sponsors: Duke University; Duke University; The Medicines Company
Recruiting - verified December 2011 - Condition: Schizophrenia
Interventions: Drug: Asenapine 10 mg once daily in the evening; Drug: Asenapine 5 mg twice daily
Sponsors: Duke University; Duke University; Merck
Not yet recruiting - verified March 2012 - Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib; Drug: Pomalidomide; Drug: Dexamethasone
Sponsors: Academic Myeloma Consortium; Academic Myeloma Consortium; CORE Science Solutions; Onyx Pharmaceuticals; Celgene Corporation
Recruiting - verified February 2012 - Condition: Urinary Tract Infection
Intervention: Drug: Nitrofurantoin
Sponsors: Duke University; Duke University
Recruiting - verified October 2011 - Conditions: HIV; AIDS; Obesity
Intervention: Drug: antiretroviral therapy
Sponsors: Duke University; Duke University; Janssen, LP
Active, not recruiting - verified October 2011 - Conditions: Nausea; Vomiting; Glioma
Interventions: Drug: Aprepitant and Ondansetron; Drug: Ondansetron
Sponsors: Duke University; Duke University; Merck
Not yet recruiting - verified March 2012 - Condition: Ankle Osteoarthritis
Intervention: Other: Total Ankle Replacement Surgery
Sponsors: Duke University; Duke University
Recruiting - verified January 2012 - Conditions: Post-operative Complications; Surgical Site Infection; Surgical Wound Infection
Interventions: Device: Prevena™ Incision Management System (PIMS); Device: Standard-of-care Dressing
Sponsors: KCI USA, Inc.; KCI USA, Inc.
Recruiting - verified February 2012 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN); Drug: Ribavirin (RBV); Drug: Boceprevir (BOC)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: Smoking Cessation
Interventions: Drug: Meclizine; Drug: Nicotine patches
Sponsors: Duke University; Duke University; Philip Morris USA, Inc.
Recruiting - verified March 2012 - Condition: Hepatitis C, Chronic
Intervention:
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified January 2012 - Condition: Hepatitis C, Chronic
Intervention:
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified January 2012 - Conditions: Myocardial Infarction; Ventricular Dysfunction; Sudden Death; Ventricular Tachycardia; Ventricular Fibrillation
Intervention: Device: wearable defibrillator
Sponsors: Zoll Medical Corporation; Zoll Medical Corporation; University of California, San Francisco
Recruiting - verified May 2012 - Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Condition: Pulmonary Hypertension
Intervention: Drug: Anakinra 100 mg subcutaneously daily
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University
Recruiting - verified November 2011 - Conditions: Heart Failure; Cardiomyopathy; Ventricular Dysfunction
Interventions: Biological: Mesenchymal Precursor Cell Injection; Biological: 50% Alpha-MEM/42.5% ProFreeze NAO Freezing Medium/7.5% DMSO
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Hypoplastic Left Heart Syndrome
Interventions: Other: Autologous Umbilical Cord Blood; Other: Autologous Umbilical Cord Blood
Sponsors: Duke University; Duke University
Recruiting - verified September 2011 - Condition: Heart Failure
Interventions: Device: Implanatable Cardioverter-Defibrillator (subject's pre-existing ICD); Device: Implantable Cardioverter-Defibrillator (subject's pre-exisiting ICD)
Sponsors: Duke University; Duke University; Medtronic
Recruiting - verified October 2011 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: Cobicistat; Drug: Darunavir
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified October 2011 - Conditions: Coronary Artery Disease; Angina Pectoris
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: breast imaging study; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Procedure: neoadjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Conditions: Prematurity; Respiratory Disease
Intervention:
Sponsors: University of Pennsylvania; University of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Osteoarthritis
Interventions: Behavioral: Patient Behavioral Intervention for OA; Behavioral: Provider Intervention for OA; Behavioral: Combined Patient and Provider Interventions for OA
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified September 2011 - Condition: Healthy
Intervention: Drug: gadofosveset
Sponsors: Duke University; Duke University; Lantheus Medical Imaging
Active, not recruiting - verified January 2012 - Condition: Prediabetes
Interventions: Behavioral: Lifestyle Intervention; Behavioral: Structured and Guided Education
Sponsors: Duke University; Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Conditions: Pathology of Posterior Fossa; Lung Cancer; Flank Pain; Urolithiasis; Focal Liver Lesion
Intervention:
Sponsors: GE Healthcare; GE Healthcare; American College of Radiology - Image Metrix
Recruiting - verified January 2012 - Conditions: Cardiac Arrest; Pulseless Electrical Activity; Asystole
Intervention:
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester; North Shore University Hospital; New York University School of Medicine; Mount Sinai Hospital, New York; Washington University School of Medicine; University of New Mexico; Advocate Health Care; University of California, Irvine; University of Utah; Carolinas Medical Center; Emory University; Louisiana State University Health Sciences Center in New Orleans; Duke University; Brigham and Women's Hospital; Massachusetts General Hospital; Rhode Island Hospital; Christiana Care Health Services; George Washington University; Kingston General Hospital; University of Ottawa; Jewish General Hospital; Horizon Health Network, Saint John Zone; York Hospitals; Boston Medical Center; Indiana University; Yale University; Queen's Medical Centre; University of Hawaii; Stanford University
Recruiting - verified April 2012 - Condition: Cancer of the Endometrium
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified November 2011 - Conditions: Sepsis; Shock, Septic
Interventions: Device: NICOM; Other: Usual care
Sponsors: National University Hospital, Singapore; National University Hospital, Singapore; Singapore Clinical Research Institute
Recruiting - verified September 2011 - Condition: Sturge-Weber Syndrome
Intervention:
Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; National Institutes of Health (NIH); University of California, San Francisco; National Institute of Neurological Disorders and Stroke (NINDS); Duke University; Children's Hospital of Michigan; Baylor College of Medicine; Texas Children's Hospital; Wills Eye; Nationwide Children's Hospital
Recruiting - verified February 2012 - Condition: Breast Cancer
Interventions: Device: AeroForm Patient Controlled Tissue Expander; Procedure: Implantation of Saline Tissue Expander
Sponsors: AirXpanders, Inc.; AirXpanders, Inc.
Recruiting - verified April 2012 - Condition: Severe Open Fractures of the Tibia (Shin) Bone
Interventions: Procedure: Surgery with an external ring fixator; Procedure: Definitive fixation with a locked IM nail or plate
Sponsors: Major Extremity Trauma Research Consortium; Major Extremity Trauma Research Consortium; Department of Defense
Recruiting - verified April 2012 - Conditions: Sickle Cell Disease; Vaso-occlusive Crisis
Interventions: Drug: Placebo; Drug: Dalteparin
Sponsors: Duke University; Duke University; Eisai Limited
Recruiting - verified August 2011 - Conditions: Infection; Hypertension; Anesthesia; Pain; Reflux
Intervention:
Sponsors: Duke University; Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); The EMMES Corporation
Recruiting - verified April 2012 - Conditions: Anemia, Sickle Cell; Thalassemia
Intervention: Biological: Hematopoietic stem cell transplantation
Sponsors: University of Louisville; University of Louisville; Duke University; Department of Defense; National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified December 2011 - Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Healthy
Intervention: Device: O2 MedTech cerebral oximeter (Oxygen desaturation)
Sponsors: O2 MedTech, Inc.; O2 MedTech, Inc.; Duke University
Recruiting - verified August 2011 - Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Heart, Lung, and Blood Institute (NHLBI); Children's Hospital Boston; Children's Hospital Medical Center, Cincinnati; University of Texas Southwestern Medical Center; Children's Healthcare of Atlanta; Children's Hospital of Philadelphia; The Hospital for Sick Children; Children's Research Institute; Columbia University; St. Jude Children's Research Hospital; Virginia Commonwealth University; Rainbow Babies Hospital; University of South Alabama; Medical University of South Carolina; Cohen Children's Medical Center; University of Alabama at Birmingham; University of Miami; University of Mississippi Medical Center; Wayne State University; Children's Hospital of The King's Daughters; Nemours Children's Clinic; Duke University; East Carolina University; Children's Hospitals and Clinics of Minnesota; Children's Memorial Hospital
Recruiting - verified March 2012 - Condition: Uncontrolled Hypertension
Intervention: Device: Renal denervation (Symplicity Catheter System)
Sponsors: Medtronic Vascular; Medtronic Vascular
Recruiting - verified May 2012 - Conditions: Posttraumatic Stress Disorder; Traumatic Brain Injury
Interventions: Drug: Methylphenidate Hydrochloride 20 mg; Drug: Placebo Capsule; Drug: Galantamine 12 mg
Sponsors: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; U.S. Army Medical Research and Materiel Command
Recruiting - verified January 2012 - Condition: Pancreatic Cancer
Interventions: Drug: GVAX Pancreas, Cyclophosphamide and CRS-207; Drug: GVAX Pancreas and Cyclophosphamide
Sponsors: Aduro BioTech, Inc.; Aduro BioTech, Inc.; Johns Hopkins University
Recruiting - verified May 2012 - Conditions: Unspecified Child Maltreatment, Suspected; Unspecified Child Maltreatment, Confirmed
Intervention: Other: Durham Connects
Sponsors: Duke University; Duke University; The Duke Endowment; The Pew Charitable Trusts
Active, not recruiting - verified July 2011 - Condition: HIV-1 Infection
Interventions: Drug: Atripla; Drug: Calcium Carbonate; Drug: Vitamin D3; Drug: Placebo for calcium carbonate; Drug: Placebo for vitamin D3
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Epilepsy
Intervention:
Sponsors: Royal College of Surgeons, Ireland; Royal College of Surgeons, Ireland; St. James's Hospital; University College, London; Erasme University Hospital; Duke University
Not yet recruiting - verified July 2011 - Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Palonosetron; Drug: Ondansetron
Sponsors: Helsinn Healthcare SA; Helsinn Healthcare SA
Recruiting - verified January 2012 - Condition: Ulcerative Colitis
Intervention: Drug: Methotrexate
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Reflux; Gastroesophageal Reflux Disease (GERD)
Intervention:
Sponsors: Duke University; Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Pulmonary Arterial Hypertension
Intervention:
Sponsors: Actelion; Actelion; Canadian Heart Research Centre
Recruiting - verified April 2012 - Condition: Pulmonary Coin Lesion
Intervention: Procedure: Lung biopsy using Always On EM Tip Tracked Device
Sponsors: Veran Medical Technologies; Veran Medical Technologies; Institute for Quality Resource Management
Recruiting - verified July 2011 - Condition: Epilepsy, Partial Seizures
Interventions: Drug: Pregabalin add-on therapy; Drug: Pregabalin add-on therapy; Drug: Pregabalin add-on therapy
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Lurasidone
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Condition: Traumatic Brain Injury
Interventions: Behavioral: Individualized Scheduled Telephone Support (ISTS); Other: Usual Care (UC)
Sponsors: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; U.S. Army Medical Research and Materiel Command
Recruiting - verified July 2011 - Conditions: Prostate Cancer; Metastatic
Intervention: Drug: BKM120
Sponsors: Duke University; Duke University; Novartis Pharmaceuticals
Recruiting - verified October 2011 - Conditions: Proteinuria; Idiopathic Membranous Nephropathy
Interventions: Drug: Repository Corticotropin Injection; Drug: Placebo
Sponsors: Questcor Pharmaceuticals, Inc.; Questcor Pharmaceuticals, Inc.
Recruiting - verified January 2012 - Condition: Peripheral Arterial Disease
Intervention: Drug: sodium nitrite
Sponsors: TheraVasc Inc.; TheraVasc Inc.
Recruiting - verified March 2012 - Condition: Acute Myeloid Leukemia
Intervention:
Sponsors: Center for International Blood and Marrow Transplant Research; Center for International Blood and Marrow Transplant Research; Resource for Clinical Investigations in Blood and Marrow Transplantation (RCI-BMT); Pediatric Blood and Marrow Transplant Consortium
Recruiting - verified May 2012 - Conditions: Heart Diseases; Arrhythmia; Atrial Fibrillation
Intervention: Device: THERMOCOOL® SMARTTOUCH™ Catheter
Sponsors: Biosense Webster, Inc.; Biosense Webster, Inc.
Active, not recruiting - verified January 2012 - Condition: Diabetic Kidney Disease
Intervention:
Sponsors: Duke University; Duke University
Active, not recruiting - verified December 2011 - Conditions: Percutaneous Coronary Intervention; Ischemic Symptoms
Interventions: Procedure: Transradial PCI; Procedure: Transfemoral PCI
Sponsors: Duke University; Duke University; American College of Cardiology Foundation, Abbott Vascular, Lilly USA, Medtronic, Terumo Medical Corporation, The Medicines Company
Enrolling by invitation - verified October 2011 - Condition: Pompe Disease
Intervention: Drug: duvoglustat hydrochloride
Sponsors: Amicus Therapeutics; Amicus Therapeutics
Recruiting - verified February 2012 - Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: Raltegravir; Drug: Raltegravir; Drug: Tenofovir; Drug: Tenofovir; Drug: Ritonavir; Drug: Atazanavir
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Chronic Hepatitis C
Interventions: Drug: GS-5885, GS-9451, PEG , RBV; Drug: PEG, RBV
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified February 2012 - Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected WomenConditions: Human Immunodeficiency Virus (HIV); Self-efficacy; Self-esteem
Intervention: Behavioral: Ipod video
Sponsors: Duke University; Duke University; National Institute of Nursing Research (NINR)
Not yet recruiting - verified July 2011 - Conditions: Depression; HIV
Intervention: Other: Measurement-Based Care collaborative depression management
Sponsors: Duke University; Duke University; National Institute of Mental Health (NIMH); University of North Carolina, Chapel Hill; University of Alabama at Birmingham
Recruiting - verified June 2011 - Condition: Breast Cancer
Intervention:
Sponsors: Duke University; Duke University; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Intervention: Drug: Lenalidomide + Plerixafor (+ Rituximab)
Sponsors: Duke University; Duke University; Celgene Corporation; Genzyme
Recruiting - verified January 2012 - Conditions: Peanut Hypersensitivity; Food Hypersensitivity; Food Allergy; Peanut Allergy
Intervention: Drug: Liquid peanut extract
Sponsors: Duke University; Duke University; National Institute of Allergy and Infectious Diseases (NIAID); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified June 2011 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Methamphetamine Dependence; Cocaine Dependence
Interventions: Drug: OND-PR002 and MPh-IR; Other: Placebo: Two dextrose capsules for Ond-PR002 and MPh-IR
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Enrolling by invitation - verified September 2011 - Conditions: Inherited Metabolic Disorder of Nervous System; Amino Acid Metabolism, Inherited Disorders
Intervention: Biological: Stem Cell Transplantation
Sponsors: University of Louisville; University of Louisville; Duke University
Active, not recruiting - verified December 2011 - Conditions: Congenital Cytomegalovirus Infection; Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified June 2011 - Condition: Prostate Cancer
Interventions: Drug: Pazopanib; Drug: Docetaxel; Drug: Pazopanib; Drug: Prednisone
Sponsors: Duke University; Duke University; GlaxoSmithKline
Recruiting - verified July 2011 - Conditions: Breast Cancer; Ovarian Cancer; Colon Cancer; Thrombophilia
Intervention:
Sponsors: The Moses H. Cone Memorial Hospital; The Moses H. Cone Memorial Hospital; Duke University; University of North Carolina, Greensboro
Enrolling by invitation - verified June 2011 - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Rifapentine (RPT); Drug: Isoniazid (INH); Dietary Supplement: Pyridoxine (Vitamin B6)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: GS-5885 tablet; Drug: GS-9451 tablet; Biological: peginterferon alfa-2a; Drug: ribavirin tablet
Sponsors: Gilead Sciences; Gilead Sciences
Active, not recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Device: NEST-1 (NeoSync EEG Synchronized TMS); Device: SHAM
Sponsors: NeoSync, Inc.; NeoSync, Inc.
Recruiting - verified May 2012 - Condition: Hepatitis B
Interventions: Drug: Tenofovir; Drug: Combination of peginterferon alfa 2a and tenofovir
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pittsburgh
Not yet recruiting - verified February 2012 - Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pittsburgh
Not yet recruiting - verified January 2012 - Conditions: Arthrodesis; Degenerative Arthritis; Rheumatoid Arthritis; Complications; Arthroplasty, Mechanical
Intervention:
Sponsors: Wright Medical Technology; Wright Medical Technology; Duke University
Recruiting - verified June 2011 - Condition: Patients in Need of Lung Transplant
Intervention: Drug: Ex vivo lung perfusion with Steen Solution™
Sponsors: XVIVO Perfusion; XVIVO Perfusion
Recruiting - verified September 2011 - Condition: Congestive Heart Failure
Interventions: Device: HeartWare® VAS; Other: Optimal Medical Management
Sponsors: University of Michigan; University of Michigan; HeartWare, Inc.; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified January 2012 - Condition: HIV-1 Infection
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Tenofovir disoproxil fumarate; Drug: Emtricitabine; Drug: Placebo for Tenofovir disoproxil fumarate; Drug: Placebo for Maraviroc
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified September 2011 - Conditions: Myopia; Obesity
Intervention: Behavioral: Family-based Outdoor program
Sponsors: National University, Singapore; National University, Singapore
Active, not recruiting - verified July 2011 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: bortezomib; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: mitoxantrone hydrochloride; Drug: sorafenib tosylate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Radiation: radiation therapy; Radiation: selective external radiation therapy
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: paclitaxel; Other: pharmacological study; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group
Recruiting - verified May 2012 - Conditions: Major Depressive Disorder, Recurrent, Unspecified; Major Depressive Disorder, Single Episode, Unspecified
Intervention: Other: H-Coil Deep TMS in combination with SSRIs
Sponsors: Brainsway; Brainsway
Not yet recruiting - verified May 2011
 |
Duke University - Database of Clinical Trials by Pharmaceutical Companies |
